A cancer researcher who recently retired from MD Anderson Cancer Center — and also recently lost seven papers from one journal following a multi-year investigation — is one of the world’s top scientists, according to a new ranking. In Thomson Reuters Web of Science’s 2015 list of The World’s Most Influential Scientific Minds, Bharat Aggarwal’s name tops the section … Continue reading Author with seven retractions makes Thomson Reuters list of top scientists — plus another twist
An MD Anderson Cancer Center researcher who has been under investigation by the institution for at least several years has had seven papers retracted from a single journal. Bharat Aggarwal told us in 2012 that MD Anderson was investigating his work, but in 2013 threatened to sue us for reporting on the case. Aggarwal is … Continue reading Journal retracts 7 papers by MD Anderson cancer researcher long under investigation
Who has the most retractions? Here’s our unofficial list (see notes on methodology), which we’ll update as more information comes to light: Joachim Boldt (213) See also: Editors-in-chief statement, our coverage Yoshitaka Fujii (172) See also: Final report of investigating committee, our reporting, additional coverage Hironobu Ueshima (124) See also: our coverage Yoshihiro Sato (122) … Continue reading The Retraction Watch Leaderboard
Bharat Aggarwal, the MD Anderson researcher who has threatened to sue Retraction Watch for writing about issues in his papers, has corrected another study. Here’s the notice for “Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation … Continue reading Cancer researcher who threatened to sue Retraction Watch corrects another paper
Readers of this blog — and anyone who has been following the Anil Potti saga — know that MD Anderson Cancer Center was the source of initial concerns about the reproducibility of the studies Potti, and his supervisor, Joseph Nevins, were publishing in high profile journals. So the Houston institution has a rep for dealing … Continue reading Half of researchers have reported trouble reproducing published findings: MD Anderson survey
Yesterday, we reported that Sunil Kumar Manna, the head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, had retracted two papers for image problems. Turns out Manna will be retracting eight more, he told us today. Here they are:
The head of immunology at India’s Centre for DNA Fingerprinting and Diagnostics, Sunil Kumar Manna, has retracted two papers for image problems. Here’s the notice from Cell Death and Differentiation for “Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells:”
A cancer researcher once involved in a federal research integrity probe has repeatedly been denied funding and other sources of income, according to his attorney, who blamed our coverage of the case for the scientist’s continuing woes and asked us to remove a post. [Please see an update on this post.] Our coverage of the … Continue reading Attorney asks Retraction Watch to remove post because client has lost out on opportunities
Ten years. On Aug. 3, 2010, we published our first post on Retraction Watch. Titled, “Why write a blog about retractions?”, the welcome letter to readers outlined our hopes for the new blog. Retractions, we felt then, offered “a window into the scientific process,” as well as a source of good stories for journalists. In … Continue reading Retraction Watch turns 10: A look back, and a look forward
In April 2012, we wrote about a case of disputed authorship and misused data involving one Varun Kesherwani, a former postdoc at the University of Nebraska. As we reported then, Kesherwani was first author of a paper in Cytokine. The second author, Ajit Sodhi, of Banaras Hindu University, claimed to have had no knowledge of … Continue reading Former postdoc threatens Retraction Watch with lawsuit over vague defamation claims